Quo vadis, Cor et Vasa? Plány nové redakční rady

Michael Aschermann

Cor Vasa 2008, 50(7-8):277  

Co pro mne znamená "návrat ztraceného dítěte"

Jaroslav Hořejší

Cor Vasa 2008, 50(7-8):278-279  

Vážené kolegyně, vážení kolegové, milí čtenáři Cor et Vasa

Václav Chaloupka

Cor Vasa 2008, 50(7-8):279  

Cardiopulmonary mechanical support in a Pediatric Heart Center

Pavel Vojtovič, Vladimír Kučera, Tomáš Tláskal, Tomáš Matějka, Roman Gebauer, Jan Janoušek, Bohumil Hučín, Oleg Reich, Ivana Černá, Jitka Kuzinová, Jan Škovránek

Cor Vasa 2008, 50(7-8):281-286 | DOI: 10.33678/cor.2008.098  

Aim: A pooled analysis of the experience of a single center with the use of mechanical circulatory and ventilatory support in pediatric patients in the treatment of circulatory and respiratory failure unresponsive to conservative therapy.Methods: A retrospective study of all pediatric patients treated by cardiopulmonary (CP) mechanical support in the Pediatric Heart Center of Prague-based Motol University Hospital, with emphasis on the risk factors affecting mortality in this patient population.Group of patients: Over the years 1991-2007, we performed CP mechanical support in 38 children aged 1 day-17.9 years (median 2.2 years) with a body...

Cardiovascular issues of dialysis patients referred for ultrasound examination of vascular access grafts

Vladimír Tuka, Jan Malík, Vladimír Tesař

Cor Vasa 2008, 50(7-8):287-291 | DOI: 10.33678/cor.2008.099  

Aims: Patients with end-stage renal disease have high morbidity and mortality rates. The one-year mortality is 20-23%, with cardiovascular disease accounting for almost 43%. The aim of the present study was to describe cardiovascular epidemiology in patients referred for specialist ultrasound examination of their grafts.Methods: In our department, we investigate patients with grafts every 3 months after access creation. The patients come with a form completed by the nephrologist, which contains data regarding the patient's history of cardiovascular disease and their risk factors.Results: Coronary heart disease was present in 47% of patients,...

The utilization of cardiopulmonary exercise testing in cardiology

Jan Bajorek

Cor Vasa 2008, 50(7-8):292-298 | DOI: 10.33678/cor.2008.100  

Cardiopulmonary exercise testing (spiroergometry) provides a comprehensive perspective of exercise physiology and pathophysiology. The article summarizes indications and overviews current knowledge and evidence concerning clinical use of the method in practical cardiology. Attention is given to results that can be used to establish the prognosis of and to treatment in patients with heart failure and, in the second part, to the contribution of the method to the differential diagnosis of dyspnea. The described principle of the determination of ventilatory limitation under maximum load suggests the position of the method in the diagnostic algorithm for...

Combination therapy with epoprostenol and sildenafil in a female patient with severe pulmonary arterial hypertension

Jana Marešová, Pavel Jansa, David Ambrož, Pavel Poláček, Ludmila Jelínková, Michael Aschermann, Aleš Linhart

Cor Vasa 2008, 50(7-8):299-303 | DOI: 10.33678/cor.2008.101  

The mainstay of treatment of pulmonary arterial hypertension is specific pharmacotherapy (with prostanoids, endothelin receptor antagonists, phosphodiesterase 5 inhibitors). Patients with severe pulmonary arterial hypertension have recently been shown to benefit from combination specific therapy as this therapy - by affecting several pathogenic mechanisms - is capable of stabilizing the clinical presentation of this serious condition necessarily deteriorating over time.

První zkušenosti s CT koronarografií

Adriana Mifková, Josef Novotný

Cor Vasa 2008, 50(7-8):304 | DOI: 10.33678/cor.2008.102  

Akutní disekce aorty vzniklá v poporodním období

Daniela Škombárová, Petr Němec, Radim Kučera, Petr Pokorný, Mirka Krupová

Cor Vasa 2008, 50(7-8):305 | DOI: 10.33678/cor.2008.103  

Z vědeckých akcí

Cor Vasa 2008, 50(7-8):K100-107  

ENHANCE trial. Effect of Combination Ezetimibe and High-Dose Simvastatin vs Simvastatin Alone on the Atherosclerosis Process in Patients with Heterozygous Familial Hypercholesterolemia

Hana Rosolová

Cor Vasa 2008, 50(7-8):306-308  

The paper presents the results of the ENHANCE trial, a double-blind, randomized, 24-month study assessing 720 patients with familiar hypercholesterolemia. The study was designed to compare the efficacy of lipid-lowering therapy with 80 mg simvastatin + 10 mg ezetimibe versus therapy with 80 mg simvastatin on carotid and femoral intima-media thickness (IMT), as assessed by repeat ultrasound. Combination therapy did not result in significant changes in IMT over monotherapy, although simvastatin plus ezetimibe significantly reduced the levels of LDL-cholesterol and C-reactive protein compared with the group of patients treated with simvastatin alone....

Zápisy ze schůzí

Cor Vasa 2008, 50(7-8):K115-117  

Den mladých kardiologů

11. června 2008, Hradec Králové

Cor Vasa 2008, 50(7-8):K120-127  

ECHODNY 2008

19.-20. září 2008, Český Krumlov

Cor Vasa 2008, 50(7-8):K129-140  

Vliv jednání a chování sestry a její "image" na průběh hospitalizace nemocného

Andrea Pokorná, Marta Šenkyříková

Cor Vasa 2008, 50(7-8):K112-114  

Instructions to Authors

Cor Vasa 2008, 50(7-8):K141-142  

Předplatné

Cor Vasa 2008, 50(7-8):K143-144  

The role of social and economic factors in the prevention of cardiovascular disease

Jan Bruthans

Cor Vasa 2008, 50(7-8):309-312 | DOI: 10.33678/cor.2008.105  

In the industrialized nations, a lower socioeconomic status (SES) is associated with higher cardiovascular (CV) morbidity and mortality as a result of a higher prevalence of smoking, overweight and obesity, lower physical activity, higher blood pressure, more frequent hyperlipidemia and diabetes, adverse psychosocial factors (social exclusion, stress, depression, anxiousness, hostility) and poorer patients' compliance with physician's instructions regarding prevention and treatment among individuals of lower social standing. Conventional CV risk factors will explain about half of the social gradient in the coronary heart disease (CHD) risk; CV prevention...

O ctižádostech předsedů

Cor Vasa 2008, 50(7-8):K99  

Medaile profesora Václava Libenského

Cor Vasa 2008, 50(7-8):K108-111  

Přehled vzdělávacích akcí subkatedry kardiologie IPVZ ve II. pololetí 2008

Cor Vasa 2008, 50(7-8):K118-119